2Bone RC,Balk RA,Cerra FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM consensus conference committee.American college of chest physicians/society of critical care medicine[J].Chest,1992,101 (6):1644-1655.
3Levy MM,Fink MP,Marshall JC,et al.2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference[J].Intensive Care Med,2003,29 (4):530-538.
4Marshall JC,Cook DJ,Cristou NV,et al.Multiple organ dysfunction score:a reliable descriptor of a complex clinical outcome[J].Crit Care Med,1995,23 (10):1638-1652.
5Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Intensive Care Med,2004,30 (4):536-555.
6Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the united states:analysis of incidence,outcome,and associated costs of care[J].Crit Care Med,2001,29(7):1303-1310.
8Finfer S,Bellomo R,Lipman J,et al.Adult population incidence of severe sepsis in australian and new zealand intensive care units[J].Intensive Care Med,2004,30(4):589-596.
9Rivers E,Nguyen B,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368 -1377.
10DeBacker D,CreteurJ,Silva E,et al.Effects of dopamine,norepinephrine,and epinephrine on the splanchnic circulationin septic shock:which is best[J].Crit Care Med,2003,31 (6):1659-1667.
3Rivers E,Nguyen B,Havstad S,et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001,345 (19) : 1368-1377.
4Gao F,Melody T,Daniels DF,et al. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care, 2005,9 (6):R764-770.
5[4]Weil MH,Shubin H,Carlson R.Trcatmen of circulatory shock:use of aympathomimetia and related vasoactive agents[J].JAMA,1975,231 (1):1280-1286.
